TD Cowen Reiterates Buy Rating on UroGen Pharma (URGN)

June 13, 2024 2:21 PM EDT Send to a Friend
(Updated - June 13, 2024 2:21 PM EDT)

TD Cowen analyst Tara Bancroft reiterated a Buy rating on UroGen ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login